NO vascular control in Duchenne muscular dystrophy
- 1 January 2001
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 7 (1) , 27-29
- https://doi.org/10.1038/83309
Abstract
A new investigation into Duchenne muscular dystrophy (DMD) pathogenesis suggests that at least part of the muscle degeneration observed in DMD patients may result from the reduced production of muscle membrane-associated neuronal nitric oxide synthase. This reduction may lead to impaired regulation of the vasoconstrictor response and eventual muscle damage.Keywords
This publication has 16 references indexed in Scilit:
- Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophyProceedings of the National Academy of Sciences, 2000
- Molecular basis of muscular dystrophiesMuscle & Nerve, 2000
- Impaired metabolic modulation of α-adrenergic vasoconstriction in dystrophin-deficient skeletal muscleProceedings of the National Academy of Sciences, 1998
- mdx muscle pathology is independent of nNOS perturbationHuman Molecular Genetics, 1998
- ATP-sensitive potassium channels mediate contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle.Journal of Clinical Investigation, 1997
- Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy.Proceedings of the National Academy of Sciences, 1996
- Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophyCell, 1995
- Mechanical function of dystrophin in muscle cells.The Journal of cell biology, 1995
- Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscleNature, 1990
- Association of dystrophin and an integral membrane glycoproteinNature, 1989